Piscitelli SC, Pavel AB, McHale K, Jett JE, et al. A Phase 1b, Randomized, Single-Center Trial of Topical Cerdulatinib (DMVT-502) in Patients with Mild-to-Moderate Atopic Dermatitis. J Invest Dermatol 2021 Jan 22. pii: S0022-202X(21)00013.
PMID: 33493530